The rationale for dose intensity is based on pre-clinical observations in experimental model systems of cancer as well as upon retrospective studies correlating the impact of dose intensity upon response rates and survival.

Ozols, R., Thigpen, J., Dauplat, J., Colombo, N., Piccart, M., Bertelsen, K., et al. (1993). Advanced ovarian cancer. Dose intensity. ANNALS OF ONCOLOGY, 4(4), S49-S56 [10.1093/annonc/4.suppl_4.S49].

Advanced ovarian cancer. Dose intensity

COLOMBO, NICOLETTA;
1993

Abstract

The rationale for dose intensity is based on pre-clinical observations in experimental model systems of cancer as well as upon retrospective studies correlating the impact of dose intensity upon response rates and survival.
Articolo in rivista - Articolo scientifico
Randomized Controlled Trials as Topic; Prospective Studies; Bone Marrow Transplantation; Ovarian Neoplasms; Clinical Trials as Topic; Female; Carboplatin; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Humans; Cisplatin
English
1993
4
4
S49
S56
none
Ozols, R., Thigpen, J., Dauplat, J., Colombo, N., Piccart, M., Bertelsen, K., et al. (1993). Advanced ovarian cancer. Dose intensity. ANNALS OF ONCOLOGY, 4(4), S49-S56 [10.1093/annonc/4.suppl_4.S49].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/27489
Citazioni
  • Scopus 21
  • ???jsp.display-item.citation.isi??? 13
Social impact